Ambergen Products
Proteomic Analysis
Protein LabelingtRNA based reagents for cell-free expression of proteins and proteomic libraries that incorporate tags for rapid protein detection and isolation. Products include Fluorotect™ sold through Promega Corp. and PC-SNAG. See also tRNA mediated protein engineering (TRAMPE) |
Biomarker and Drug DiscoveryA massively parallel proteomic platform for biomarker and drug discovery based on Ambergen's proprietary Libraries of In Vitro Expressed Proteins (LIVE-PRO) |
Photocleavable TagsNovel photocleavable (PC) reagents for purification and characterization of biomolecules including PC-biotin and PC-ICAT. These products are based on Ambergen's proprietary Photocleavable Linker Technology (see also Genomic Analysis) |
Cell-free Expressed AntigensSpecially engineered cell-free expressed antigens can be used in a variety of biomedical assays including for detection of autoimmune and tumor asscociated antibodies. These antigens are also used in Ambergen's proprietary T2-ELISA assays. |
Genomic Analysis
Photocleavable PhosphoramiditesPhotocleavable (PC) modifiers including PC Biotin Phosphoramidite, PC Amino-Modifier Phosphoramidite and PC Spacer Phosphoramidite which can be incorporated into DNA/RNA during automated synthesis for photoreversible labeling. Sold by Glenn Research. |
PC-FLUOROTAG- NTPsA new class of NTPs with fluroescent labels which can be be rapidly removed with short light exposure. Applications include massively parallel DNA sequencing. |
PC-DNA-Polypeptide Hybridization TagsProprietary Photocleavable (PC) DNA-Polypeptide conjugates that can be used in biomedical assays to rapidly identify multiple mutations by using mass spectrometry to decode the photocleavable tag |
High Sensitivity Multiplex Mutation ScanningA genomic platform that can scan regions of a gene for mutations at much higher sensitivity than conventional DNA sequencing based on Ambergen's proprietary MASSIVE-PRO technology. |
Signature Cancer Assays
CRC-ProScreen SignatureBased on a simple blood test, this assay detects CRC using Ambergen's proprietary cell-free protein expression technology. |
CRC-Recurrence SignatureComplete Assay for Recurrence Likelihood Assessment Ambergen's Colorectal Recurrence Signature test is a clinical assay that can indicate the likelihood of recurrence after standard treatment. |
Breast-Platinum Response SignatureTest for effectiveness of Platinum Therapy |
Ovarian-Platinum Response SignatureTest for effectiveness of Platinum Therapy |
Genetic Disorders
Colorectal Cancer-IDAn assay to scan for chain truncating mutations in the APC gene associated with an inherited form of colorectal cancer (CRC) using Ambergen's proprietary ELISA-PTT technology. |
Neurofibromatosis-IDAn assay to scan for chain truncating mutations in the NF1&NF2 genes associated with neurofibromatosis based on Ambergen's proprietary ELISA-PTT technology. |
Drug Resistance Assays
CML-DRA blood test to identify with high sensitivity mutations associated with Gleevec resistance in Chronic Myelogenous Leukemia (CML) patients based on Ambergen's proprietary Mass Spectrometry of In vitro Expressed Protein (MASSIVE-PRO) technology. |
HIV-DRA blood test to identify with high sensitivity viral mutations associated with resistance to anti-viral drug treatment for HIV patients based on Ambergen's proprietary Mass Spectrometry of In vitro Expressed Protein (MASSIVE-PRO) technology. |
How to Order
Please contact sales at
sales@ambergen.com
Custom Products
Ambergen's laboratory and production facilities can help bring your research to life. Learn More >
Product Licensing
Use of Ambergen products for research, product line integration, and bundling. Learn More >